4.6 Letter

Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1)

Journal

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2018-318124

Keywords

-

Funding

  1. Stanley Medical Research Institute [14T-004]
  2. MRC [MC_PC_13073, MR/N019067/1, MR/J012939/1] Funding Source: UKRI

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Gut dysbiosis in severe mental illness and chronic fatigue: a novel trans-diagnostic construct? A systematic review and meta-analysis

Jenelle Marcelle Safadi, Alice M. G. Quinton, Belinda R. Lennox, Philip W. J. Burnet, Amedeo Minichino

Summary: Reduced gut-microbial diversity, or gut dysbiosis, has been linked to an anhedonic/amotivational syndrome, or sickness behavior, in patients with severe mental disorders and chronic fatigue. Elevated levels of proxy biomarkers of gut dysbiosis were found in patients compared to healthy controls, and these markers were positively correlated with the severity of sickness behavior. Further research comparing trans-diagnostic and categorical approaches is necessary for potential advancement in treatment for these conditions.

MOLECULAR PSYCHIATRY (2022)

Article Clinical Neurology

The impact of smoking cessation on multiple sclerosis disease progression

Jeff Rodgers, Tim Friede, Frederick W. Vonberg, Cris S. Constantinescu, Alasdair Coles, Jeremy Chataway, Martin Duddy, Hedley Emsley, Helen Ford, Lennora Fisniku, Ian Galea, Timothy Harrower, Jeremy Hobart, Huseyin Huseyin, Christopher M. Kipps, Monica Marta, Gavin McDonnell, Brendan McLean, Owen R. Pearson, David Rog, Klaus Schmierer, Basil Sharrack, Agne Straukiene, Heather C. Wilson, David Ford, Rod M. Middleton, Richard Nicholas

Summary: The negative impact of smoking in multiple sclerosis is well documented, but there is limited evidence on the benefits of smoking cessation for disease progression. This study found that current smokers had higher disability scores compared to those who had never smoked, and there was no improvement in scores with increasing time since quitting. However, when smokers quit, the rate of motor disability deterioration slowed down to match that of non-smokers. This suggests that smoking cessation is beneficial for people with multiple sclerosis.

BRAIN (2022)

Article Psychiatry

Unusual experiences and their association with metacognition: investigating ASMR and Tulpamancy

Emma Palmer-Cooper, Nicola McGuire, Abigail Wright

Summary: The study found group differences in hallucination-proneness and metacognitive beliefs in Tulpamancer and Autonomous Sensory Meridian Response (ASMR) communities, with Tulpamancer+ group scoring higher in hallucination-proneness and reporting lower levels of metacognitive belief endorsement. However, there were no group differences in delusion-proneness, self-reflection, or self-schemas.

COGNITIVE NEUROPSYCHIATRY (2022)

Article Clinical Neurology

Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses

Edward J. Needham, Alexander L. Ren, Richard J. Digby, Emma J. Norton, Soraya Ebrahimi, Joanne G. Outtrim, Doris A. Chatfield, Anne E. Manktelow, Maya M. Leibowitz, Virginia F. J. Newcombe, Rainer Doffinger, Gabriela Barcenas-Morales, Claudia Fonseca, Michael J. Taussig, Rowan M. Burnstein, Romit J. Samanta, Cordelia Dunai, Nyarie Sithole, Nicholas J. Ashton, Henrik Zetterberg, Magnus Gisslen, Arden Eden, Emelie Marklund, Peter J. M. Openshaw, Jake Dunning, Michael J. Griffiths, Jonathan Cavanagh, Gerome Breen, Sarosh R. Irani, Anne Elmer, Nathalie Kingston, Charlotte Summers, John R. Bradley, Leonie S. Taams, Benedict D. Michael, Edward T. Bullmore, Kenneth G. C. Smith, Paul A. Lyons, Alasdair J. Coles, David K. Menon

Summary: COVID-19 and influenza are both associated with brain injury, particularly in severe cases. The brain injury occurs in the context of dysregulated immune responses, with no single pathogenic mechanism clearly responsible. Blood biomarkers can be used to assess the extent and duration of brain injury.

BRAIN (2022)

Review Psychology, Clinical

Network analysis studies in patients with eating disorders: A systematic review and methodological quality assessment

Giuliano Tomei, Maria Francesca Pieroni, Elena Tomba

Summary: This systematic review evaluates the methodological quality of cross-sectional network analysis (NA) studies conducted on eating disorder (ED) clinical populations. The results indicate that while most studies adopt basic procedures for reliable results, important procedures related to NA study validity are largely neglected.

INTERNATIONAL JOURNAL OF EATING DISORDERS (2022)

Article Biochemistry & Molecular Biology

The serum metabolomic profile of a distinct, inflammatory subtype of acute psychosis

Belinda Lennox, Wenzheng Xiong, Patrick Waters, Alasdair Coles, Peter B. Jones, Tianrong Yeo, Jeanne Tan May May, Ksenija Yeeles, Daniel Anthony, Fay Probert

Summary: Some studies suggest that a proportion of psychosis may have an autoimmune basis, but there is currently no biochemical test able to accurately identify inflammation-related psychosis. In a study of acute psychosis patients, distinct clinical and biochemical phenotypes were found in a subgroup of patients, indicating a potential inflammatory subtype.

MOLECULAR PSYCHIATRY (2022)

Article Clinical Neurology

Remyelination varies between and within lesions in multiple sclerosis following bexarotene

J. William L. Brown, Ferran Prados, Daniel R. Altmann, Baris Kanber, Jonathan Stutters, Nick G. Cunniffe, Joanne L. Jones, Zoya G. Georgieva, Edward J. Needham, Cyrus Daruwalla, Claudia Gandini Wheeler-Kingshott, Peter Connick, Siddharthan Chandran, Robin Franklin, David MacManus, Rebecca Samson, Alasdair Coles, Declan Chard

Summary: This study found that treatment response varies depending on the location and degree of abnormality in patients with multiple sclerosis. The remyelinating effect is more pronounced in gray matter lesions, and the post-processing of whole gray matter lesion measures is simpler and may reduce sample sizes.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2022)

Article Clinical Neurology

Autologous haematopoietic stem cell transplantation for immune-mediated neurological diseases: what, how, who and why?

Gavin Brittain, Alasdair J. Coles, G. Giovannoni, Paolo Antonio Muraro, Jacqueline Palace, Jennifer Petrie, Elisa Roldan, N. J. Scolding, John A. Snowden, Basil Sharrack

Summary: In carefully selected patients, autologous HSCT is a safe and highly effective treatment for immune-mediated neurological disorders. Limited understanding has caused confusion, mistrust, and an increase in health tourism.

PRACTICAL NEUROLOGY (2023)

Article Clinical Neurology

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

Cyrus Daruwalla, Vahid Shaygannejad, Serkan Ozakbas, Eva Kubala Havrdova, Dana Horakova, Raed Alroughani, Cavit Boz, Francesco Patti, Marco Onofrj, Alessandra Lugaresi, Sara Eichau, Marc Girard, Alexandre Prat, Pierre Duquette, Bassem Yamout, Samia J. Khoury, Seyed Aidin Sajedi, Recai Turkoglu, Ayse Altintas, Olga Skibina, Katherine Buzzard, Pierre Grammond, Rana Karabudak, Anneke van der Walt, Helmut Butzkueven, Davide Maimone, Jeannette Lechner-Scott, Aysun Soysal, Nevin John, Julie Prevost, Daniele Spitaleri, Cristina Ramo-Tello, Oliver Gerlach, Gerardo Iuliano, Matteo Foschi, Radek Ampapa, Vincent van Pesch, Michael Barnett, Nevin Shalaby, Marie D'hooghe, Jens Kuhle, Maria Jose Sa, Marzena Fabis-Pedrini, Allan Kermode, Saloua Mrabet, Riadh Gouider, Suzanne Hodgkinson, Guy Laureys, Liesbeth Van Hijfte, Richard Macdonell, Celia Oreja-Guevara, Edgardo Cristiano, Pamela McCombe, Jose Luis Sanchez-Menoyo, Bhim Singhal, Yolanda Blanco, Stella Hughes, Justin Garber, Claudio Solaro, Chris McGuigan, Bruce Taylor, Koen de Gans, Mario Habek, Abdullah Al-Asmi, Simu Mihaela, Tamara Castillo Trivino, Talal Al-Harbi, Juan Ignacio Rojas, Orla Gray, Dheeraj Khurana, Bart Van Wijmeersch, Nikolaos Grigoriadis, Jihad Inshasi, Jiwon Oh, Eduardo Aguera-Morales, Yara Fragoso, Fraser Moore, Cameron Shaw, Seyed Mohammad Baghbanian, Neil Shuey, Barbara Willekens, Todd A. Hardy, Danny Decoo, Angel Perez Sempere, Deborah Field, Ray Wynford-Thomas, Nick G. Cunniffe, Izanne Roos, Charles B. Malpas, Alasdair J. Coles, Tomas Kalincik, J. William L. Brown, MSBase Study Grp

Summary: This study found that early non-disabling relapses in people with RRMS are associated with a higher risk of disability accumulation, which may be mitigated by high-efficacy DMTs. Therefore, treatment decisions should take into account the impact of non-disabling relapses.

MULTIPLE SCLEROSIS JOURNAL (2023)

Editorial Material Clinical Neurology

Chasing MOG antibodies down... assays and lumbar punctures

Alasdair J. Coles

BRAIN (2023)

Article Clinical Neurology

The relationship between dysfunctional attitudes, maladaptive perfectionism, metacognition and symptoms of mania and depression in bipolar disorder: The role of self-compassion as a mediating factor

Emma C. Palmer-Cooper, Chloe Woods, Thomas Richardson

Summary: This study explored the associations between maladaptive cognitions and mood symptoms in bipolar disorder (BD) and found that maladaptive metacognitions predicted future depression severity. The relationship between maladaptive cognitions and depression was partially mediated by self-compassion, while the relationship with mania was weak and suggested that self-compassion could increase mania.

JOURNAL OF AFFECTIVE DISORDERS (2023)

Review Public, Environmental & Occupational Health

Wellbeing among university students during the COVID-19 pandemic: a systematic review of longitudinal studies

Anais Lemyre, Emma Palmer-Cooper, Jane P. Messina

Summary: The study aimed to investigate the wellbeing trajectories of university students during the COVID-19 pandemic and identify associated protective factors. A systematic review of English-language articles was conducted, and the results showed a significant decrease in wellbeing during the early stages of the pandemic compared to prepandemic times. However, there were mixed findings in later phases, with some studies showing improvement, others showing no change, and two studies finding impairments. Overall, wellbeing was associated with factors such as gender, socioeconomic status, sleep and physical activity, social connectedness, alcohol use, and social media activity.

PUBLIC HEALTH (2023)

Article Medicine, General & Internal

Mapping the Path to Cognitive Balance: Applying the States of Mind Model and Network Analysis to Eating Disorder Patients

Lucia Tecuta, Giuliano Tomei, Raymond Digiuseppe, Romana Schumann, Donatella Ballardini, Elena Tomba

Summary: This study tested the clinical utility of the states of mind model (SOM) in a sample of eating disorder outpatients. The results showed that SOM could differentiate patients from controls and capture more severe psychopathology and compromised psychological well-being in patients. This suggests that SOM might be a potential clinical index in cognitive-behavioral therapy for eating disorders.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Psychology, Clinical

Are dysfunctional attitudes elevated and linked to mood in bipolar disorder? A systematic review and meta-analysis

Chloe Woods, Thomas Richardson, Emma Palmer-Cooper

Summary: Dysfunctional attitudes (DA) are significantly higher in bipolar disorder (BD) compared to healthy controls, but no difference is observed between BD and unipolar participants. Mood state has a significant impact on DA scores in BD, with higher scores in depressed participants. Psychological therapies appear to reduce DA in BD.

BRITISH JOURNAL OF CLINICAL PSYCHOLOGY (2023)

Article Clinical Neurology

Safety and efficacy with alemtuzumab over 13?years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study

Alasdair J. Coles, Anat Achiron, Anthony Traboulsee, Barry A. Singer, Carlo Pozzilli, Celia Oreja-Guevara, Gavin Giovannoni, Giancarlo Comi, Mark S. Freedman, Tjalf Ziemssen, Debora Shiota, Andreea M. Rawlings, Alana T. Wong, Magdalena Chirieac, Xavier Montalban

Summary: The safety risks associated with alemtuzumab treatment decreased over time, and the clinical benefits were maintained for 11-13 years, with most patients not requiring additional courses.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2023)

No Data Available